Aniara
 
 

Clotting method

 
HEMOCLOT Quanti V-L (CE Marked)
For Research Use Only in the United States and Canada

Clotting, Deficient Plasmas, & Chromogenic Assays products are available worldwide

 

Clotting method for the quantitative measurement of Factor V-L (Factor V Leiden) concentration in citrated plasma, by its resistance to the action of Activated Protein C (APC). The assay is performed in the presence of Activated Protein C and Protein S (one single test for each patient). In the presence of APC, the prolongation of clotting time is an inverse relationship of the concentration of Factor V-Leiden (mutation R506Q). Normal Factor V is not measured.

Assay characteristics
Kit components
Applications
Total Assay Time:                                                < 5 min.
Detection Threshold:                                                  < 1%
Dynamic Range:                                                0 to 100%
Intra-Assay CV:                                                        < 3%
Inter-Assay CV:                                                        < 5%
No Significant interference of:    Heparin, Bilirubin, Hemoglobin
Number of tests:                                                3x20 tests
R1: 3x2 mL Clotting mixture (h-Fibrinogen, h-Prothrombin and Protein S)
R2: 3x1ml FXa and phospholipids
Quantitative measurement of FV-L, resistant to the action of Activated Protein C, for diagnosing patients carrying the R506Q FV mutation (Factor V-Leiden), or any FV mutant resistant to APC.

 

  Link to more information

 

Streamline laboratory procedures! Click here for ready-to-use reagents and buffers, from Medicago AB. Available in tablets and pouches!

INFORMATION
SKU ID # Packaging Package Inserts MSDS Adaptations Price
ACK065K Set of 3x20 tests $280.00
ORDER NOW

Back to Clotting method




Company I Products I How To Order I Technical Data & Documentation I Research Discount I Industry Resources
Contact Us I Site Map I Home I Terms & Conditions I Privacy Policy

Design and Support Services by Liaison Marketing Communications.